PTK2 and small cell lung carcinoma: IHC in 85 human SCLC tissues revealed that total FAK was localized to the cytoplasm of 78/85 (92%) SCLCs, and that its expression was low in 11 (13%), moderate in 17 (20%), and high in 50 (59%) SCLCs [24].